Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/13/2001 | US6187560 Nucleotide sequences coding mitochondrial polypeptide; for the treatment of dietetics, diabetes, hyperlipidemia and weight defects |
02/13/2001 | US6187309 Method for treatment of symptoms of central nervous system disorders |
02/13/2001 | US6187308 Ameliorating an immune response disorder. |
02/13/2001 | US6187287 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells |
02/13/2001 | US6187284 Reacting a peptide comprising a free thiol group with an 18 f-bound labelling reagent which also has a group that is reactive with thiols. |
02/13/2001 | CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable |
02/13/2001 | CA2150344C Method for producing exogenous protein |
02/13/2001 | CA2079230C Bcrf1 antagonists for treating epstein-barr virus infections |
02/13/2001 | CA2067334C Recombinant production of lactoperoxidase |
02/10/2001 | WO2001032871A2 Follistatin-related protein zfsta4 |
02/10/2001 | CA2389956A1 Follistatin-related protein zfsta4 |
02/08/2001 | WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof |
02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
02/08/2001 | WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
02/08/2001 | WO2001009313A1 G-protein coupled receptor and dna sequences thereof |
02/08/2001 | WO2001009293A2 Mammalian adhesion protease peptides |
02/08/2001 | WO2001009290A2 Avian infectious bronchitis virus serotype |
02/08/2001 | WO2001009289A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
02/08/2001 | WO2001009193A1 Chimeric polypeptides, method for production and uses thereof |
02/08/2001 | WO2001009192A1 Human monoclonal antibodies to prostate specific membrane antigen |
02/08/2001 | WO2001009191A1 Computational design methods for making molecular mimetics |
02/08/2001 | WO2001009190A2 Monoclonal antibodies to tacrolimus and immunoassay methods for tacrolimus |
02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
02/08/2001 | WO2001009187A2 Human monoclonal antibodies to her2/neu |
02/08/2001 | WO2001009186A2 Therapeutic compounds comprised of anti-fc receptor binding agents |
02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
02/08/2001 | WO2001009178A2 Human chaperone proteins |
02/08/2001 | WO2001008700A1 Preventing immune-mediated abortion by inhibiting costimulation |
02/08/2001 | WO2001008636A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein |
02/08/2001 | WO2001008635A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
02/08/2001 | WO2001008634A2 Polynucleotide encoding a human serine protease |
02/08/2001 | WO2000076540A3 Streptococcus pneumoniae proteins and vaccines |
02/08/2001 | WO2000075317A3 Compositions and methods for the treatment of tumor |
02/08/2001 | WO2000067785A3 Staphyloccocus aureus antigen-containing whole cell vaccine |
02/08/2001 | WO2000063230A3 49 human secreted proteins |
02/08/2001 | WO2000062815A3 Novel pharmaceutical composition suitable for gene therapy |
02/08/2001 | WO2000061756A3 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
02/08/2001 | WO2000061183A3 Verotoxin treatment of lymphomas |
02/08/2001 | WO2000060355A3 Lfa-1 regulatory binding site and uses thereof |
02/08/2001 | WO2000059525A3 USE OF ErbB RECEPTOR LIGANDS IN TREATING DIABETES |
02/08/2001 | WO2000053758A3 Compositions and methods for the treatment of immune related diseases |
02/08/2001 | WO2000053755A3 Compositions and methods for the treatment of tumor |
02/08/2001 | WO2000020864A8 Immunotherapy of b cell involvement in progression of solid, nonlymphoid tumors |
02/08/2001 | DE19937230A1 Chimäre Proteine Chimeric proteins |
02/08/2001 | DE19936563A1 Tumorassoziiertes Antigen Tumor-associated antigen |
02/08/2001 | CA2697207A1 Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications |
02/08/2001 | CA2381945A1 Mammalian adhesion protease peptides |
02/08/2001 | CA2381565A1 Therapeutic compounds comprised of anti-fc receptor binding agents |
02/08/2001 | CA2381437A1 G-protein coupled receptor and dna sequences thereof |
02/08/2001 | CA2380822A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
02/08/2001 | CA2380813A1 Human monoclonal antibodies to her2/neu |
02/08/2001 | CA2380803A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
02/08/2001 | CA2380515A1 Polypeptides and polynucleotides from moraxella catarrhalis |
02/08/2001 | CA2380407A1 Method for in vitro culture of viruses of the togaviridae and flaviviridae family and uses |
02/08/2001 | CA2380295A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
02/08/2001 | CA2379360A1 Human g-protein coupled receptor |
02/08/2001 | CA2378929A1 Serine proteases |
02/08/2001 | CA2378331A1 Calcium channel transport polynucleotides, polypeptides, and antibodies |
02/08/2001 | CA2378182A1 Compositions and methods for the treatment of tumors |
02/08/2001 | CA2377244A1 Computational design methods for making molecular mimetics |
02/08/2001 | CA2374743A1 Human chaperone proteins |
02/07/2001 | EP1074842A1 Catalytic anti-factor VIII allo-antibodies |
02/07/2001 | EP1074627A2 25-hydroxyvitamin D3-1a-hydroxylase and DNA encoding the hydroxylase |
02/07/2001 | EP1074625A2 DNA vaccine against feline immunodeficiency virus |
02/07/2001 | EP1074623A1 ABC transporter |
02/07/2001 | EP1074618A2 Cadherin materials and methods |
02/07/2001 | EP1074563A1 Chimeric polypeptides enhancing dimer formation through electrostatic interactions and disulfide bond, method for production and uses thereof |
02/07/2001 | EP1074562A1 Monoclonal antibody directed against the thrombin-antithrombin III complex and its use in immunoassays |
02/07/2001 | EP1074559A1 Peptide nucleic acids |
02/07/2001 | EP1074268A1 Preventives or remedies for inflammatory intestinal diseases containing as the active ingredient il-6 antagonists |
02/07/2001 | EP1074266A2 Live attenuated bacteria for use in a vaccine |
02/07/2001 | EP1073905A1 Methods of selecting internalizing antibodies |
02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
02/07/2001 | EP1073743A1 Flowering locus t (ft) and genetically modified plants having modulated flower development |
02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
02/07/2001 | EP1073739A2 Cd40-interacting and traf-interacting proteins |
02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
02/07/2001 | EP1073723A2 Ste20-related protein kinases |
02/07/2001 | EP1073716A2 Improvements in or relating to separation processes |
02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
02/07/2001 | EP1073671A1 Targeted gene delivery to cells by filamentous bacteriophage |
02/07/2001 | EP1073669A2 Gcp |
02/07/2001 | EP1073465A1 T cell inhibitory receptor compositions and uses thereof |
02/07/2001 | EP1073464A1 Monoclonal antibodies with reduced immunogenicity |
02/07/2001 | EP1073463A1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
02/07/2001 | EP1073461A1 Viral chimeras comprised of caev and hiv-1 genetic elements |